Form 4: Danaher Corp Director Feroz Dewan Reports Acquisition of Phantom Shares

Director Feroz Dewan reports acquiring phantom shares convertible to Danaher common stock through a deferred compensation plan.

Summary

• On October 25, 2024, Feroz Dewan, a director of Danaher Corp, acquired 128.568 phantom shares under the Non-Employee Directors Deferred Compensation Plan.
• These phantom shares are convertible to Danaher common stock on a one-for-one basis.
• The price of Danaher's common stock on the transaction date was $245.39.
• Following the transaction, Dewan beneficially owns 1,236.621 shares.
• The reporting person is fully vested in all amounts deferred under the Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company through a standard compensation plan.

Positives

• The acquisition of phantom shares reflects Dewan's continued investment in Danaher Corp.
• The deferred compensation plan aligns director compensation with the company's long-term performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Comparison to Industry Standards

• Deferred compensation plans for directors are a common practice among publicly traded companies, including Danaher's peers such as Thermo Fisher Scientific and Abbott Laboratories.
• These plans typically allow directors to defer cash fees and convert them into company stock, aligning their interests with shareholders.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency into director compensation and alignment with shareholder interests.

Key Dates